Agilent Technologies (A)
(Delayed Data from NYSE)
$142.92 USD
+0.39 (0.27%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $142.86 -0.06 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$142.92 USD
+0.39 (0.27%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $142.86 -0.06 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Zacks News
Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.
Agilent (A) Surpasses Earnings and Revenue Estimates in Q1
by Zacks Equity Research
Agilent (A) reports strong fiscal first-quarter results on broad-based growth in all its product lines.
Agilent Technologies (A) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of 4.11% and 1.02%, respectively, for the quarter ended January 2019. Do the numbers hold clues to what lies ahead for the stock?
Wal-Mart, CVS, Agilent, Hewlett-Packard and Kraft-Heinz are part of Zacks Earnings Preview
by Zacks Equity Research
Wal-Mart, CVS, Agilent, Hewlett-Packard and Kraft-Heinz are part of Zacks Earnings Preview
Will New Technologies Benefit Agilent (A) in Q1 Earnings?
by Zacks Equity Research
Agilent's (A) leadership position and strength in revenue segments are likely to aid fiscal first-quarter 2019 results.
3 Things to Know About Q4 Earnings Season
by Sheraz Mian
We continue to see the picture that emerged from the Q4 earnings season as not great, but it is not bad either.
Agilent Technologies (A) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Agilent (A) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Agilent (A) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
TE Connectivity (TEL) Q1 Earnings: What's in the Cards?
by Zacks Equity Research
TE Connectivity's (TEL) fiscal first-quarter 2019 results are expected to benefit from robust solutions portfolio and normalizing seasonal trend in the end-markets.
What's in the Offing for Waters Corp (WAT) in Q4 Earnings?
by Zacks Equity Research
Waters' (WAT) strong segmental and end-market performance is likely to drive fourth-quarter 2018 results.
Will Agilent (A) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Agilent (A) to Expand Cell Analysis Offerings in Ireland
by Zacks Equity Research
Agilent (A) is set to expand the Cork facility in Ireland in a bid to expand its capabilities in the cell analysis space.
Agilent Technologies (A) in Focus: Stock Moves 7.8% Higher
by Zacks Equity Research
Agilent Technologies (A) shares rose almost 8% in the last trading session, amid huge volumes.
Agilent (A) Surpasses Earnings and Revenue Estimates in Q4
by Zacks Equity Research
Agilent (A) reports strong fiscal fourth-quarter results on broad-based growth in all its product lines.
Agilent Technologies (A) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of 10.96% and 3.05%, respectively, for the quarter ended October 2018. Do the numbers hold clues to what lies ahead for the stock?
Agilent (A) Hikes Quarterly Dividend, Rewards Shareholders
by Zacks Equity Research
Agilent (A) hikes dividend to 16.4 cents per share in a bid to reward its shareholders.
Will New Technologies Benefit Agilent (A) in Q4 Earnings?
by Zacks Equity Research
Agilent's (A) leadership position and strength in revenue segments are likely to aid fiscal fourth-quarter 2018 results.
Agilent Technologies (A) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Automotive Strength & Acquisitions Aid AVX Q2 Earnings?
by Zacks Equity Research
AVX's fiscal second-quarter results are likely to benefit from acquisitions and strength in the automotive market. However, weakness in the smartphone market might impact its results.
Agilent Technologies Enters Oversold Territory
by Zacks Equity Research
Agilent Technologies has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
TER vs. A: Which Stock Is the Better Value Option?
by Zacks Equity Research
TER vs. A: Which Stock Is the Better Value Option?
Agilent Technologies (A): Moving Average Crossover Alert
by Zacks Equity Research
Agilent Technologies, Inc. (A) is looking like an interesting pick from a technical perspective
Agilent Eyes Cell Analysis Portfolio Expansion, To Buy ACEA
by Zacks Equity Research
Agilent (A) agrees to acquire ACEA Biosciences (ACEA) for $250 million, in a bid to expand its share in the cell analysis market.
TER vs. A: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
TER vs. A: Which Stock Is the Better Value Option?
Electronics Testing Equipment Outlook: Solid Demand Ahead
by Zacks Equity Research
Electronics - Testing Equipment industry has growth potential, thanks to increasing proliferation of electronic devices in every major sector.
Why Is Agilent (A) Up 4.9% Since Last Earnings Report?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.